6021 - 6030 of 8620 Results
Title
Year
-
OPENTitle: Activation mechanism of PINK1Journal Name: NaturePublisher: Springer Science and Business Media LLCVol: 602Issue #: 7896Start Page: 328End Page: 335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-021-04340-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8828467Citation Count: 88
-
RESTRICTEDTitle: Dysregulated miRNAs mark Parkinson’s disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2Citation Count: 1
- Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue2021OPENTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://escholarship.org/content/qt0nc5b6ht/qt0nc5b6ht.pdfCitation Count: 42
-
OPENTitle: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 6Start Page: 550End Page: 565Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1Citation Count: 37
- Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease2021OPENTitle: Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-22399-3Best OA location URL: https://www.nature.com/articles/s41467-021-22399-3.pdfCitation Count: 69
- Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologies2021OPENTitle: Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25680-7Best OA location URL: https://www.nature.com/articles/s41467-021-25680-7.pdfCitation Count: 15
- Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease2021OPENTitle: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 787End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00847-6Best OA location URL: http://hdl.handle.net/1887/3249471Citation Count: 116
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture2021OPENTitle: Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 3Start Page: 294End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00785-3Best OA location URL: https://escholarship.org/uc/item/7qn6v913Citation Count: 314
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial2021RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 103
- Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis2021OPENTitle: Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesisJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 2Start Page: 143End Page: 146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-020-00773-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8130821Citation Count: 292